HIGHLIGHTS
- who: Hongrui Guo from the (UNIVERSITY) have published the article: Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib, in the Journal: (JOURNAL) of 27/Oct/2021
- what: The study demonstrates a Official journal of CDDpress 2 novel signaling pathway that mediates HCC progression produced by CYB5A.
- how: These results indicated that CYB5A is frequently downregulated in HCC patients and may act as a predictor for HCC survival and recurrence. To detect the occurrence of autophagy after CYB5A overexpression or knockdown the authors conducted immunocytochemistry . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.